Increases in Methamphetamine Use Among Heroin Treatment Admissions in the United States, 2008-17

Overview

Journal Addiction

Specialty Psychiatry

Date 2019 Sep 11

PMID 31503384

Citations 74

Authors

Christopher M Jones

Natasha Underwood

Wilson M Compton

Affiliations

Soon will be listed here.

Abstract

Background And Aims: Due to their small sample sizes, geographic specificity and limited examination of socio-demographic characteristics, recent studies of methamphetamine use among people using heroin in the United States are limited in their ability to identify national and regional trends and to characterize populations at risk for using heroin and methamphetamine. This study aimed to examine trends and correlates of methamphetamine use among heroin treatment admissions in the United States.

Design: Longitudinal analysis of data from the 2008 to 2017 Treatment Episode Data Set. Descriptive statistics, trend analyses and multivariable logistic regression were used to examine characteristics associated with methamphetamine use among heroin treatment admissions.

Setting: United States.

Participants: Treatment admissions of people aged ≥ 12 years whose primary substance of use is heroin.

Measurements: Primary measurement was heroin treatment admissions involving methamphetamine. Secondary measurements were demographics of sex, age, race/ethnicity, US census region, living arrangement and employment status.

Findings: The percentage of primary heroin treatment admissions reporting methamphetamine use increased each year from 2.1% in 2008 to 12.4% in 2017, a relative percentage increase of 490% and an annual percentage change (APC) of 23.4% (P < 0.001). During the study period, increases were seen among males and females and among all demographic and geographic groups examined. Among primary heroin treatment admissions reporting methamphetamine use in 2017, 47.1% reported injecting, 46.0% reported smoking, 5.1% reporting snorting and 1.8% reported oral/other as their usual route of methamphetamine use.

Conclusions: Methamphetamine use among heroin treatment admissions in the United States increased from one in 50 primary heroin treatment admissions in 2008 to one in 8 admissions in 2017.

Citing Articles

Pipe Distribution as a Harm Reduction Service for People Who Use Methamphetamine.

Rains A, Augustine E, Miller K, Bresett J, Bolinski R, Thompson T Subst Use Misuse. 2024; 60(4):558-565.

PMID: 39702015 PMC: 11825270. DOI: 10.1080/10826084.2024.2440379.

Association of Daily Doses of Buprenorphine With Urgent Health Care Utilization.

Axeen S, Pacula R, Merlin J, Gordon A, Stein B JAMA Netw Open. 2024; 7(9):e2435478.

PMID: 39320889 PMC: 11425142. DOI: 10.1001/jamanetworkopen.2024.35478.

Cross sectional analysis of an addiction consultation service, substance co-use patterns, and receipt of medications for opioid use disorder during hospitalization.

Shearer R, Bart G, Beebe T, Virnig B, Shippee N, Winkelman T J Subst Use Addict Treat. 2024; 167:209505.

PMID: 39241929 PMC: 11527587. DOI: 10.1016/j.josat.2024.209505.

Behavioral and Health Outcome Differences by Heroin or Methamphetamine Preference Among People in Rural US Communities Who Use Both Substances.

Mixson L, Whitney B, Jenkins W, Stopka T, Korthuis P, Drumright L Subst Use. 2024; 18:29768357241272374.

PMID: 39175912 PMC: 11339740. DOI: 10.1177/29768357241272374.

Internalized Stigma Measurement in Substance Use Treatment Settings: A Narrative Review.

Joseph V, Pearson M, Witkiewitz K Addict Res Theory. 2024; 32(3):160-166.

PMID: 38799505 PMC: 11114794. DOI: 10.1080/16066359.2023.2227090.

References

Al-Tayyib A, Koester S, Langegger S, Raville L . Heroin and Methamphetamine Injection: An Emerging Drug Use Pattern. Subst Use Misuse. 2017; 52(8):1051-1058. PMC: 5642954. DOI: 10.1080/10826084.2016.1271432. View

Hser Y, Evans E, Huang Y . Treatment outcomes among women and men methamphetamine abusers in California. J Subst Abuse Treat. 2005; 28(1):77-85. DOI: 10.1016/j.jsat.2004.10.009. View

Prakash M, Tangalakis K, Antonipillai J, Stojanovska L, Nurgali K, Apostolopoulos V . Methamphetamine: Effects on the brain, gut and immune system. Pharmacol Res. 2017; 120:60-67. DOI: 10.1016/j.phrs.2017.03.009. View

Kim H, Fay M, Feuer E, Midthune D . Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000; 19(3):335-51. DOI: 10.1002/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z. View

Cheng W, Garfein R, Semple S, Strathdee S, Zians J, Patterson T . Increased drug use and STI risk with injection drug use among HIV-seronegative heterosexual methamphetamine users. J Psychoactive Drugs. 2010; 42(1):11-8. PMC: 2907747. DOI: 10.1080/02791072.2010.10399781. View

Voce A, Calabria B, Burns R, Castle D, McKetin R . A Systematic Review of the Symptom Profile and Course of Methamphetamine-Associated Psychosis. Subst Use Misuse. 2019; 54(4):549-559. DOI: 10.1080/10826084.2018.1521430. View

Darke S, Kaye S, Duflou J . Rates, characteristics and circumstances of methamphetamine-related death in Australia: a national 7-year study. Addiction. 2017; 112(12):2191-2201. DOI: 10.1111/add.13897. View

De Crescenzo F, Ciabattini M, DAlo G, De Giorgi R, Del Giovane C, Cassar C . Comparative efficacy and acceptability of psychosocial interventions for individuals with cocaine and amphetamine addiction: A systematic review and network meta-analysis. PLoS Med. 2018; 15(12):e1002715. PMC: 6306153. DOI: 10.1371/journal.pmed.1002715. View

Degenhardt L, Sara G, McKetin R, Roxburgh A, Dobbins T, Farrell M . Crystalline methamphetamine use and methamphetamine-related harms in Australia. Drug Alcohol Rev. 2016; 36(2):160-170. DOI: 10.1111/dar.12426. View

10.

Glick S, Burt R, Kummer K, Tinsley J, Banta-Green C, Golden M . Increasing methamphetamine injection among non-MSM who inject drugs in King County, Washington. Drug Alcohol Depend. 2017; 182:86-92. PMC: 6457905. DOI: 10.1016/j.drugalcdep.2017.10.011. View

11.

Ellis M, Kasper Z, Cicero T . Twin epidemics: The surging rise of methamphetamine use in chronic opioid users. Drug Alcohol Depend. 2018; 193:14-20. DOI: 10.1016/j.drugalcdep.2018.08.029. View

12.

Cunningham E, Jacka B, DeBeck K, Applegate T, Harrigan P, Krajden M . Methamphetamine injecting is associated with phylogenetic clustering of hepatitis C virus infection among street-involved youth in Vancouver, Canada. Drug Alcohol Depend. 2015; 152:272-6. PMC: 4461061. DOI: 10.1016/j.drugalcdep.2015.04.005. View

13.

Evans E, Kelleghan A, Li L, Min J, Huang D, Urada D . Gender differences in mortality among treated opioid dependent patients. Drug Alcohol Depend. 2015; 155:228-35. PMC: 4581957. DOI: 10.1016/j.drugalcdep.2015.07.010. View

14.

Pilowsky D, Wu L, Burchett B, Blazer D, Woody G, Ling W . Co-occurring amphetamine use and associated medical and psychiatric comorbidity among opioid-dependent adults: results from the Clinical Trials Network. Subst Abuse Rehabil. 2011; 2:133-144. PMC: 3163455. DOI: 10.2147/SAR.S20895. View

15.

Liu D, Gu J, Xu H, Hao C, Jiao M, Zhang X . Club drugs and alcohol abuse predicted dropout and poor adherence among methadone maintenance treatment patients in Guangzhou, China. AIDS Care. 2016; 29(4):458-463. PMC: 7243263. DOI: 10.1080/09540121.2016.1259452. View

16.

Barr A, Panenka W, MacEwan G, Thornton A, Lang D, Honer W . The need for speed: an update on methamphetamine addiction. J Psychiatry Neurosci. 2006; 31(5):301-13. PMC: 1557685. View

17.

Spoth R, Redmond C, Shin C, Greenberg M, Feinberg M, Trudeau L . PROSPER delivery of universal preventive interventions with young adolescents: long-term effects on emerging adult substance misuse and associated risk behaviors. Psychol Med. 2017; 47(13):2246-2259. PMC: 5963524. DOI: 10.1017/S0033291717000691. View

18.

Scholl L, Seth P, Kariisa M, Wilson N, Baldwin G . Drug and Opioid-Involved Overdose Deaths - United States, 2013-2017. MMWR Morb Mortal Wkly Rep. 2019; 67(5152):1419-1427. PMC: 6334822. DOI: 10.15585/mmwr.mm675152e1. View

19.

Darke S, Duflou J, Kaye S . Prevalence and nature of cardiovascular disease in methamphetamine-related death: A national study. Drug Alcohol Depend. 2017; 179:174-179. DOI: 10.1016/j.drugalcdep.2017.07.001. View

20.

Jalal H, Buchanich J, Roberts M, Balmert L, Zhang K, Burke D . Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016. Science. 2018; 361(6408). PMC: 8025225. DOI: 10.1126/science.aau1184. View